4 Comments
User's avatar
Kathy Boston's avatar

From US Right to Know newsletter

The White House invokes the Defense Production Act to guarantee supplies of elemental phosphorus and glyphosate-based herbicides. Regulators reapprove dicamba, a Bayer herbicide twice blocked by federal courts, and clear the way for new pesticides containing toxic, persistent PFAS “forever” chemicals.

And the U.S. Justice Department urges the Supreme Court to erase billions of dollars of Bayer’s liability for its glyphosate-based Roundup – placing the weight of the executive branch on the side of a foreign company against thousands of Americans who say Bayer’s products caused their cancers.

Over the past year, the Trump administration has delivered a string of victories to Bayer, the German agrichemical and pharmaceutical giant that merged with Monsanto in 2018 to become the world’s leading manufacturer of genetically modified seeds and pesticides.

What is Bayer’s access in Washington? Our review found 16 key administration officials with ties to Bayer’s lobbying or legal network. Bayer and its lobbyists have access to people in power at the White House, U.S. Department of Agriculture, the Environmental Protection Agency and even those in high-level positions closest to Trump.

Read Stacy Malkan’s reporting, Tracing Bayer’s ties to power in Trump’s Washington; From lobby firms to top officials, a look at how Bayer built access and secured favors

The most potent Bayer-Trump connections involve a group of Florida lobbyists and former lobbyists who hold power in Trump’s Washington: Chief of Staff Susie Wiles (left), Attorney General Pam Bondi (right), and Brian Ballard (middle), who employed both Bondi and Wiles as lobbyists for years.

Donate to Support our Right to Know

We are also tracking Bayer’s formidable lobbying force in Washington. As of the fourth quarter of 2025, the company retained 45 registered lobbyists and at least 13 outside lobby firms – seven of which are now among the highest-paid firms in D.C.

More than 30 senior officials at lobby firms retained by Bayer have direct ties to Trump, having worked in one or both of his administrations or political campaigns

Mark Brody's avatar

Some, but certainly not all rare diseases are epigenetic in nature, in my opinion. In other words, modifying environmental risk factors is sufficient in some cases to successfully treat some of these rare disease. The GAPS diet is an excellent example of this.

Kathy's avatar

I’m glad you wrote those would possibly help “some” rare diseases but genetic diseases like Huntingtons disease is absolutely devastating to a patient with it and to their families. They having nothing to treat this including just symptom control which barely work and can make things worse sometimes.

It’s like ALS and Alzheimer’s together and the poor patient just has to “live” with it.

It’s not living, it’s complete horror for the patient and families watching their decline. I had three family members with it and they provide no assistance for these patients of any kind!

Diet does NOT help in these genetic diseases, it’s the gene mutation causing it and so many of these diseases have been around decades/century

Tina Stolberg's avatar

"Rarity does not negate worth." Says it all.